Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Cryo-Cell International's share price for the quarter that ended in Feb. 2024 was $5.2. Cryo-Cell International's Shares Outstanding (EOP) for the quarter that ended in Feb. 2024 was 8.25 Mil. Therefore, Cryo-Cell International's market cap for the quarter that ended in Feb. 2024 was $42.93 Mil.
Cryo-Cell International's quarterly market cap
declined
from Aug. 2023 ($49.68 Mil) to Nov. 2023 ($44.33 Mil) and
declined
from Nov. 2023 ($44.33 Mil) to Feb. 2024 ($42.93 Mil).
Cryo-Cell International's annual market cap
declined
from Nov. 2021 ($105.94 Mil) to Nov. 2022 ($37.15 Mil) but then
increased
from Nov. 2022 ($37.15 Mil) to Nov. 2023 ($44.33 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Cryo-Cell International's Enterprise Value for Today is $70.31 Mil.
Cryo-Cell International Market Cap Historical Data
The historical data trend for Cryo-Cell International's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Cryo-Cell International Annual Data
Trend
Nov14
Nov15
Nov16
Nov17
Nov18
Nov19
Nov20
Nov21
Nov22
Nov23
Market Cap
56.71
56.59
105.94
37.15
44.33
Cryo-Cell International Quarterly Data
May19
Aug19
Nov19
Feb20
May20
Aug20
Nov20
Feb21
May21
Aug21
Nov21
Feb22
May22
Aug22
Nov22
Feb23
May23
Aug23
Nov23
Feb24
Market Cap
32.25
40.19
49.68
44.33
42.93
Competitive Comparison
For the Medical Care Facilities subindustry, Cryo-Cell International's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cryo-Cell International Market Cap Distribution
For the Healthcare Providers & Services industry and Healthcare sector, Cryo-Cell International's Market Cap distribution charts can be found below:
* The bar in red indicates where Cryo-Cell International's Market Cap falls into.
Cryo-Cell International Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Cryo-Cell International's Market Cap for the fiscal year that ended in Nov. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cryo-Cell International (AMEX:CCEL) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Cryo-Cell International Market Cap Related Terms
Thank you for viewing the detailed overview of Cryo-Cell International's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Cryo-Cell International (Cryo-Cell International) Business Description
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of Prepacyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. All the business activity of the group functions through the United States and it derives revenue from processing and testing fees and storage fees charged each year for storage and through sales of the Prepacyte CB units.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CCEL has been successfully added to your 